Caitlin Raymond – D is for Decoy: Apparent Rh-Specificity in Warm Autoantibodies
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, posted on LinkedIn:
”D is for Decoy: When “anti-D” isn’t what it seems
An O-positive patient’s plasma looked like it contained anti-D – until the autocontrol came back positive and the eluate was a panagglutinin.
That combination changes everything.
When plasma reactivity appears Rh-specific but the eluate reacts with everything, you’re not dealing with alloimmunization or passive antibody. You’re seeing an autoantibody with apparent Rh specificity – one of those beautifully deceptive patterns that teaches you to read between the agglutination lines.
In this new Blood, Bytes, and Beyond post, I walk through:
– The testing logic behind ruling out partial D and passive anti-D
– Why Rh-complex autoantibodies often mimic anti-D, anti-e, or anti-C
– How to document these cases clearly so no one chases a phantom alloantibody later
For anyone who’s ever stared at a positive autocontrol and thought “wait a second…,” this one’s for you.”
Read the full post here.

Stay informed with Hemostasis Today.
-
Jan 31, 2026, 16:35IV Thrombolysis Does Not Improve Vision in Acute CRAO: Ahmed Koriesh on TenCRAOS Study
-
Jan 31, 2026, 16:24Joyce John Chalakkal: The Dangerous Area of The Face….
-
Jan 31, 2026, 16:04Rayya Saadiq Reflects On Qatar Health Congress 2026
-
Jan 31, 2026, 15:12Amar Raval on Oral Thin Film Drug Delivery Systems for Thrombosis Therapy
-
Jan 31, 2026, 14:40Heghine Khachatryan on WFH’s Call to Advance Health Equity for People with Bleeding Disorders
-
Jan 31, 2026, 14:10Emilia Arturo: Snake Venom, Clotting, and CryoEM!
-
Jan 31, 2026, 08:13Ming Y Lim On The Value of National Mentorship
-
Jan 31, 2026, 06:37Christian Schulze Presents The Post-Hoc Analysis of the DanGer Shock Trial
-
Jan 31, 2026, 06:27Negative Trials Matter: Anne Hege Aamodt Shares The TenCRAOS Trial